Clinical trials
Phase 3 Glioblastoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 7 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| INSYS Therapeutics Inc | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| NRG Oncology | 2 |
| NovoCure Ltd. | 2 |
| Pfizer | 2 |
| Radiation Therapy Oncology Group | 2 |
| Wake Forest University Health Sciences | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 48 |
| Brain Neoplasms | 20 |
| Gliosarcoma | 13 |
| Glioma | 11 |
| Astrocytoma | 9 |
| Neoplasms | 9 |
| Central Nervous System Neoplasms | 6 |
| Oligodendroglioma | 5 |
| Choroid Plexus Neoplasms | 3 |
| Ependymoma | 3 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.